Navigation Links
Should oxygen be used for patients with chronic heart failure?
Date:5/21/2012

Researchers at the University of Hull, in the UK, have just launched a major new trial investigating the effects of home oxygen therapy in patients with chronic heart failure (CHF).

Since home oxygen therapy (HOT) can be inconvenient for patients is and expensive, a robust trial is required to offer some clear guidance about whether HOT should be offered routinely to patients with chronic heart failure.

Around 669,000 people in the UK aged over 45 have the condition, in which the heart is too weak to pump blood efficiently around the body. Chronic heart failure is frequently characterised by breathlessness, which can be worse when the patient lies down to sleep.

Although home oxygen therapy is frequently prescribed to treat the symptoms, there is no conclusive evidence as to its efficacy. Indeed, although the patient may be short of breath, this is not always linked to low blood oxygen levels.

Professor Andrew Clark, of the University of Hull, who leading the study, explains: "There is a strong belief that oxygen must be vital for patients suffering from breathlessness: however we can't be certain that home oxygen therapy is effective, particularly since we know many CHF patients who are well treated with medication have normal levels of arterial oxygen in their blood while they are at rest and during exercise."

The research was commissioned by the National Institute for Health Research Health Technology Assessment (NIHR HTA), which funds research into the effectiveness, costs and broader impacts of healthcare treatments.

Around 165 patients will be recruited to the randomised trial and given either overnight HOT, or HOT for 17 hours per day, alongside their regular medical therapies. A third group will continue to receive their normal medical therapy with no home oxygen. The trial will last for two years, during which time the research team will measure a range of factors, including the patient's overall quality of life, exercise ability and breathlessness, as well as the severity of CHF.

"The results of the research will offer clinicians useful guidance on whether home oxygen therapy is beneficial to patients with chronic heart failure," says Professor Clark. "This will enable them to better target treatments for the benefit of patients and to ensure resources are used cost-effectively."

The study will be based initially at Hull, but involving other research institutions around the UK as the study progresses.


'/>"/>

Contact: Beck Lockwood
beck@campuspr.co.uk
University of Hull
Source:Eurekalert

Related medicine news :

1. New standards for treating traumatic shoulder injuries to improve patient care
2. Canada should play a role in addressing the global cancer epidemic
3. GPs should advise drinkers to keep a daily record of their drinking
4. Should Cystic Fibrosis Patients Get So Many Antibiotics?
5. Northeast U.S. Should Brace for Spike in Lyme Disease: Expert
6. Social workers should reclaim role in juvenile corrections system, MU researcher says
7. Treatment for hip conditions should not rest solely on MRI scans
8. Experts Offer Tips on Avoiding iPad-Linked Shoulder, Neck Strain
9. Neurologists Should Screen Patients for Abuse: Experts
10. Shoulder pain from using your ipad? Dont use it on your lap
11. Ob-Gyns Should Screen for Domestic Abuse: Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and Related ... those affected by autism spectrum disorder (ASD) and other developmental disabilities. The group, which ... give parents and other caregivers the opportunity to share stories and advice, seek help, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of two ostomy patients, standing as living proof that attitude and determination can ... diseases and issues that spike around the holidays. This campaign will offer patients ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a class-leading provider of ... Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories keep track of ... new version is a faster and a more efficient product, allowing batch processing ...
(Date:12/2/2016)... ... December 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ... and night. No other wearable health technology on the market can deliver all that ... poeple more meaningful insights about their health than the usual heart rate and steps ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... needy individuals and families from eight different sites throughout Miami-Dade and Broward counties. ... 1,000 volunteers worked very hard on Thanksgiving morning by putting together individual meals ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... YORK , December 2, 2016 ... Research titled "Global Market Study on Automated Endoscope Reprocessors: Single ... a CAGR of 8.6% Between 2016 and 2024 " the global automated ... and is expected to expand at a CAGR of 7.2% ... valuation of US$ 1,367.6 Mn by 2024. ...
(Date:12/2/2016)... , Dec. 2, 2016 In the ... sources apart from those derived from C. sativa, the ... Universita` di Napoli Federico II , the Universita` ... the first comprehensive, critical, integrated and unified inventory of ... article focuses on the remarkable chemical and structural ...
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical ... den INSTI HIV-Selbsttest, bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology: